COOPERS BOVILIS PILIGUARD PINKEYE VACCINE

Država: Australija

Jezik: engleski

Izvor: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Kupi sada

Preuzimanje Uputa o lijeku (PIL)
20-06-2017
Preuzimanje Svojstava lijeka (SPC)
20-06-2017

Aktivni sastojci:

MORAXELLA BOVIS; GENTAMICIN; SALINE

Dostupno od:

INTERVET AUSTRALIA PTY LIMITED

INN (International ime):

Moraxella bovis

Farmaceutski oblik:

MISC. VACCINES OR ANTI SERA

Sastav:

MORAXELLA BOVIS IMMUNOBIOLOGICAL Active 1.0 RP/2mL D; GENTAMICIN ANTIBIOTIC Other 30.0 ug/ml; SALINE SOLVENT Other 0.48 ml/do

Jedinice u paketu:

100mL (50 doses); 20mL (10 doses)

Razred:

VM - Veterinary Medicine

Proizveden od:

INTERVET AUSTRALIA

Terapijska grupa:

CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | HEIFER | STEER

Područje terapije:

IMMUNOTHERAPY

Terapijske indikacije:

MORAXELLA SPP. | PINK-EYE

Proizvod sažetak:

Poison schedule: 0; Withholding period: WHP: Nil; Host/pest details: CATTLE: [MORAXELLA SPP., PINK-EYE]; Poison schedule: 0; Withholding period: ; Host/pest details: CATTLE: [MORAXELLA SPP., PINK-EYE]; For use in healthy cattle to aid in the prevention of pinkeye associated with infection by Moraxella bovis strains expressing pili similar to those in the vaccine.

Status autorizacije:

Registered

Datum autorizacije:

2023-07-01

Uputa o lijeku

                                COMPANY NAME:
APVMA APPROVAL NO:
LABEL NAME:
SIGNAL HEADINGS:
CONSTITUENT
STATEMENTS:
CLAIMS:
NET CONTENTS:
DIRECTIONS FOR USE:
PRECAUTIONS:
SIDE EFFECTS:
+
RLP
APPROVED
INTERVET AUSTRALIA PTY LIMITED
60802/10241 0
COOPERS BOVILIS PILl GUARD PINKEYE VACCINE
FOR ANIMAL TREATMENT ONLY
Contains chemically-inactivated cultures of Moraxella bovis isolates
(
                                
                                Pročitajte cijeli dokument
                                
                            

Svojstava lijeka

                                PRODUCT NAME: COOPERS PILIGUARD PINKEYE-1 TRIVALENT VACCINE
FOR CATTLE
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: AUGUST, 2014
PAGE: 1 OF 6
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited (known as MSD Animal Health)
Phone: 1 800 033 461 (Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Oil emulsion vaccine based on Inactivated strains of certain bacteria.
TRADE NAME:
COOPERS PILIGUARD PINKEYE-1 TRIVALENT VACCINE FOR CATTLE
RECOMMENDED USE:
Treatment and prevention of pinkeye associated with infection by
_Moraxella bovis_ strains
in cattle.
APVMA NO:
60802
THIS VERSION ISSUED:
is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S24/25. Avoid contact with skin and eyes.
SUSDP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
White liquid.
ODOUR:
No odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. In addition product is unlikely to cause any discomfort in
normal use.
LONG TERM EXPOSURE:
No data for health effects associated with long term skin exposure.
POTENTIAL HEALTH EFFECTS
EMERGENCY OVERVIEW
SECTION 2 - HAZARDS IDENTIFICATION
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
ISSUED BY: INTERVET AUSTRALIA PTY LIMITED
(KNOWN 
                                
                                Pročitajte cijeli dokument